🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the producers of Tylenol, asserting the firms withheld alleged dangers that the pain reliever created to pediatric brain development.

This legal action follows thirty days after Donald Trump advocated an unproven link between taking Tylenol - referred to as acetaminophen - throughout gestation and autism in children.

The attorney general is filing suit against Johnson & Johnson, which formerly manufactured the medication, the sole analgesic approved for pregnant women, and Kenvue, which currently produces it.

In a declaration, he said they "betrayed America by profiting off of suffering and pushing pills without regard for the risks."

The company asserts there is insufficient reliable data linking Tylenol to autism spectrum disorder.

"These corporations deceived for years, intentionally threatening numerous people to line their pockets," Paxton, a Republican, stated.

The manufacturer said in a statement that it was "seriously troubled by the perpetuation of misinformation on the safety of paracetamol and the likely effects that could have on the well-being of women and children in America."

On its official site, Kenvue also said it had "consistently assessed the relevant science and there is lacking reliable evidence that demonstrates a established connection between taking paracetamol and autism spectrum disorder."

Associations representing physicians and health professionals concur.

ACOG has declared acetaminophen - the primary component in Tylenol - is a restricted selection for expectant mothers to manage discomfort and elevated temperature, which can present serious health risks if left untreated.

"In multiple decades of research on the use of acetaminophen in gestation, zero credible investigations has conclusively proven that the usage of paracetamol in any stage of gestation leads to neurodevelopmental disorders in children," the organization stated.

The court filing cites latest statements from the previous government in asserting the medication is potentially dangerous.

Last month, Trump generated worry from health experts when he told expectant mothers to "fight like hell" not to consume Tylenol when unwell.

The FDA then issued a notice that doctors should think about restricting the use of Tylenol, while also mentioning that "a proven link" between the medication and autism in children has remains unverified.

The Health Department head Robert F Kennedy Jr, who oversees the FDA, had promised in April to conduct "extensive scientific investigation" that would identify the origin of autism spectrum disorder in a short period.

But authorities cautioned that finding a single cause of autism spectrum disorder - considered by experts to be the outcome of a complex mix of inherited and external influences - would be difficult.

Autism spectrum disorder is a category of enduring cognitive variation and impairment that impacts how individuals experience and engage with the world, and is identified using medical professional evaluations.

In his court filing, the attorney general - who supports Trump who is campaigning for the Senate - claims the manufacturer and J&J "deliberately disregarded and sought to suppress the evidence" around acetaminophen and autism spectrum disorder.

The lawsuit attempts to require the corporations "remove any commercial messaging" that states Tylenol is secure for women during pregnancy.

The Texas lawsuit echoes the complaints of a group of parents of minors with autism and ADHD who sued the producers of Tylenol in recently.

The court dismissed the case, saying studies from the plaintiffs' authorities was not conclusive.